• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

BioBehavioral Diagnostics

edit

BioBehavioral Diagnostics Company manufactures and markets the Quotientâ„¢ ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptoms. They are dedicated to providing physicians, parents and patients with high-value information to guide personalized strategies and to enhance quality of life for patients with ADHD.

Milestones

edit

• 
  BioBehavioral Diagnostics received $3.1M in Debt funding. (9/19/11)
  Posted 9/19/11 at 6:36pm via masshightech.com
• 
  BioBehavioral Diagnostics received $700k in Debt funding. (5/23/11)
  Posted 5/23/11 at 7:04pm via masshightech.com
• 
  BioBehavioral Diagnostics received $300k in Venture Round funding. (4/29/11)
  Posted 4/29/11 at 5:51pm via masshightech.com
• 
  BioBehavioral Diagnostics received $10M in Series B funding. (3/17/10)
  Posted 3/18/10 at 2:17am via onbiovc.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 3/18/10

Sources

1. BioBehavioral Diagnostics Co.: Series B $10M (onbiovc.com) [edit]
2. BioBehavioral Diagnostics takes in $300,000 (masshightech.com) [edit]
3. BioBehaviorial Diagnostics reports $700K debt round (masshightech.com) [edit]
4. ADHD device maker BioBehavioral Diagnostics rounds up $3M (masshightech.com) [edit]